| ²é¿´: 4530 | »Ø¸´: 69 | |||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û60´Î£¬×÷Õßzhuimengren639Ôö¼Ó½ð±Ò 56.5 ¸ö | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
zhuimengren639ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
|
[×ÊÔ´]
·ÖÏí£ºµÂ¹úº£µÂ±¤´óѧHugo Kubinyi½ÌÊÚµÄÒ©ÎïÉè¼ÆµÄ¿Î¼þ
|
||
|
µÂ¹úUniversity of HeidelbergµÄÖøÃûÒ©Îﻯѧ¼ÒHugo Kubinyi¹ØÓÚÒ©ÎïÉè¼ÆµÄ¿Î¼þ£¬ÏàÐŶԸãÒ©ÎïÉè¼ÆµÄͬѧ»áÓÐÓõġ£ Èç¹û¸Ð¾õµ¥¸öÏÂÔØÌ«Âé·³£¬ÄÇô¿ÉÒÔÓà flashget/ѸÀ×ÅúÁ¿ÏÂÔØ£¬Ï£Íû´ó¼ÒÄܹ»Ï²»¶£¬Ó»Ô¾ÆÀÂÛ£¡ ¿´µ½ÓÐÕâô¶à³æÓÑϲ»¶Õâ¸ö¿Î¼þ£¬ÎªÁ˸Ðл´ó¼Ò£¬ÎÒ°ÑÎÒÏÂÔØµÄ´«µ½ÄÉÃ×ÅÌÉϹ©´ó¼ÒÏÂÔØ£¬µØÖ·ÈçÏ http://www.namipan.com/d/Hugo%20 ... c4504bad9361a9db300 ÄÚÈÝ: Drug Discovery (758 kBlack Eye http://www.kubinyi.de/dd-01.pdf Serendipity and Rational Design (374 kBlack Eye http://www.kubinyi.de/dd-02.pdf Chemogenomics (1,453 kBlack Eye http://www.kubinyi.de/dd-03.pdf Ligand-Receptor Interactions (647 kBlack Eye http://www.kubinyi.de/dd-04.pdf Hydrogen Bonds and Biological Activities (359 kBlack Eye http://www.kubinyi.de/dd-05.pdf Chemical Similarity and Biological Activities (686 kBlack Eye http://www.kubinyi.de/dd-06.pdf Drug Metabolism (501 kBlack Eye http://www.kubinyi.de/dd-07.pdf Peptidomimetics and Prodrugs (294 kBlack Eye http://www.kubinyi.de/dd-08.pdf Combinatorial Chemistry Technology (147 kBlack Eye http://www.kubinyi.de/dd-09.pdf Combinatorial Chemistry in Drug Research (215 kBlack Eye http://www.kubinyi.de/dd-10.pdf QSAR Parameters (284 kBlack Eye http://www.kubinyi.de/dd-11.pdf QSAR - Hansch and Free Wilson Analyses (153 kBlack Eye http://www.kubinyi.de/dd-12.pdf Variable Selection and Model Validation (935 kBlack Eye http://www.kubinyi.de/dd-13.pdf Nonlinear QSAR and 3D QSAR (173 kBlack Eye http://www.kubinyi.de/dd-14.pdf QSAR Examples (138 kBlack Eye http://www.kubinyi.de/dd-15.pdf Structure-Based Ligand Design (782 kBlack Eye http://www.kubinyi.de/dd-16.pdf Computer-Aided Ligand Design (850 kBlack Eye http://www.kubinyi.de/dd-17.pdf Pharmacophore Analyses (486 kBlack Eye http://www.kubinyi.de/dd-18.pdf Virtual Screening (299 kBlack Eye http://www.kubinyi.de/dd-19.pdf Combinatorial and Fragment-Based Ligand Design (945 kBlack Eye http://www.kubinyi.de/dd-20.pdf Serine Proteases and their Inhibitors (371 kBlack Eye http://www.kubinyi.de/dd-21.pdf Thrombin Inhibitor Design (332 kBlack Eye http://www.kubinyi.de/dd-22.pdf Problems in Drug Design (1,043 kBlack Eye http://www.kubinyi.de/dd-23.pdf In Search for New Leads http://www.kubinyi.de/paris-07-05.pdf From Leads to Drugs http://www.kubinyi.de/wien-06-05.pdf Validation and Predictivity of QSAR Models http://www.kubinyi.de/istanbul-2004-lecture.pdf [ Last edited by zhuimengren639 on 2008-10-25 at 22:39 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¸öÈËËѼ¯¾«»ª |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çó²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ£¬080502£¬354·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085410È˹¤ÖÇÄÜר˶317Çóµ÷¼Á£¨0854¶¼¿ÉÒÔ£©
ÒѾÓÐ3È˻ظ´
330Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
3Â¥2008-10-24 21:59:33
2Â¥2008-10-24 21:09:49
5Â¥2008-10-25 03:15:15
6Â¥2008-10-25 07:02:51
¼òµ¥»Ø¸´
Àµ°±Ëá4Â¥
2008-10-24 22:03
»Ø¸´




















»Ø¸´´ËÂ¥
